Thomas E. Christos

487 total citations
16 papers, 358 citations indexed

About

Thomas E. Christos is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas E. Christos has authored 16 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas E. Christos's work include Chemical Synthesis and Analysis (5 papers), Receptor Mechanisms and Signaling (3 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Thomas E. Christos is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Receptor Mechanisms and Signaling (3 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Thomas E. Christos collaborates with scholars based in United States and Canada. Thomas E. Christos's co-authors include Douglass F. Taber, Argyrios G. Arvanitis, Ilia A. Guzei, Arnold L. Rheingold, C. Nicholas Hodge, Paul J. Gilligan, Gary A. Cain, A.L. Johnson, Kurt Steiner and Michael L. McCaleb and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Thomas E. Christos

15 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Christos United States 11 213 155 46 43 29 16 358
Paul Krenitsky United States 9 172 0.8× 104 0.7× 33 0.7× 28 0.7× 21 0.7× 10 286
Bruce M. Bechle United States 8 142 0.7× 128 0.8× 15 0.3× 19 0.4× 23 0.8× 14 257
Raymond Dagnino United States 7 167 0.8× 197 1.3× 113 2.5× 34 0.8× 59 2.0× 10 385
Jeffrey A. Deskus United States 12 230 1.1× 155 1.0× 7 0.2× 44 1.0× 6 0.2× 15 353
Paul S. Bury Denmark 10 182 0.9× 189 1.2× 18 0.4× 17 0.4× 57 2.0× 15 414
Barry M. Bloom United States 9 76 0.4× 121 0.8× 12 0.3× 35 0.8× 19 0.7× 17 269
Carolyn D. Dzierba United States 7 245 1.2× 145 0.9× 6 0.1× 16 0.4× 4 0.1× 12 342
Ravi Kurukulasuriya United States 12 240 1.1× 196 1.3× 4 0.1× 19 0.4× 117 4.0× 15 432
Horace Fletcher Hungary 9 214 1.0× 120 0.8× 4 0.1× 44 1.0× 5 0.2× 11 358
Jean Morrone United States 9 138 0.6× 191 1.2× 6 0.1× 168 3.9× 6 0.2× 9 363

Countries citing papers authored by Thomas E. Christos

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Christos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Christos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Christos more than expected).

Fields of papers citing papers by Thomas E. Christos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Christos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Christos. The network helps show where Thomas E. Christos may publish in the future.

Co-authorship network of co-authors of Thomas E. Christos

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Christos. A scholar is included among the top collaborators of Thomas E. Christos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Christos. Thomas E. Christos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Williams, David R., et al.. (2009). A general preparation of (Z)-1-fluorostilbene derivatives for the design of conformationally restricted peptidomimetics. Tetrahedron Letters. 51(1). 121–124. 16 indexed citations
2.
Taber, Douglass F., et al.. (2001). A Convenient Chiron for Substituted Cyclohexanones. The Journal of Organic Chemistry. 66(17). 5911–5914. 10 indexed citations
3.
Hodge, C. Nicholas, Paul E. Aldrich, Zelda R. Wasserman, et al.. (1999). Corticotropin-Releasing Hormone Receptor Antagonists:  Framework Design and Synthesis Guided by Ligand Conformational Studies. Journal of Medicinal Chemistry. 42(5). 819–832. 60 indexed citations
4.
Taber, Douglass F., Thomas E. Christos, Arnold L. Rheingold, & Ilia A. Guzei. (1999). Synthesis of (−)-Fumagillin. Journal of the American Chemical Society. 121(23). 5589–5590. 50 indexed citations
5.
Taber, Douglass F., et al.. (1999). Cyclization of 1,1-Disubstituted Alkenes to Cyclopentenes. The Journal of Organic Chemistry. 64(26). 9673–9678. 28 indexed citations
6.
Christos, Thomas E. & Argyrios G. Arvanitis. (1998). Corticotrophin-releasing factor receptor antagonists. Expert Opinion on Therapeutic Patents. 8(2). 143–152. 14 indexed citations
7.
Taber, Douglass F. & Thomas E. Christos. (1997). Improved chemoselectivity in intramolecular alkylidene carbene CH insertion. Tetrahedron Letters. 38(28). 4927–4930. 11 indexed citations
8.
Taber, Douglass F., Thomas E. Christos, & C. Nicholas Hodge. (1996). Cyclohexenone Annelation by Alkylidene C−H Insertion:  Synthesis of Oxo-T-cadinol. The Journal of Organic Chemistry. 61(6). 2081–2084. 21 indexed citations
9.
Taber, Douglass F., Thomas E. Christos, & C. Nicholas Hodge. (1996). ChemInform Abstract: Cyclohexenone Anellation by Alkylidene C‐H Insertion: Synthesis of Oxo‐ T‐cadinol.. ChemInform. 27(30). 1 indexed citations
10.
Kees, Kenneth L., Kurt Steiner, John J. Fitzgerald, et al.. (1995). Studies on New Acidic Azoles as Glucose-Lowering Agents in Obese, Diabetic db/db Mice. Journal of Medicinal Chemistry. 38(4). 617–628. 41 indexed citations
11.
Cain, Gary A., Thomas E. Christos, Charles J. Eyermann, et al.. (1994). Novel conformationally restricted aromatic piperidines as selective sigma receptor ligands. Bioorganic & Medicinal Chemistry Letters. 4(2). 329–334. 1 indexed citations
12.
Christos, Thomas E., Gary A. Cain, A.L. Johnson, W. Schmidt, & S. William Tam. (1994). Novel ether derivatives of alkyl piperidines as potential sigma / 5HT2 antipsychotic agents. Bioorganic & Medicinal Chemistry Letters. 4(19). 2347–2352.
13.
Cain, Gary A., Thomas E. Christos, A.L. Johnson, et al.. (1993). Neurotensin receptor binding and antinociceptive activity for lipophilic Nα-amido neurotensin(9–13) analogs. Bioorganic & Medicinal Chemistry Letters. 3(10). 2055–2060. 6 indexed citations
14.
Christos, Thomas E., Argyrios G. Arvanitis, Gary A. Cain, et al.. (1993). Stable isosteres of neurotensin c-terminal pentapeptides derived by modification of the amide function. Bioorganic & Medicinal Chemistry Letters. 3(6). 1035–1040. 17 indexed citations
15.
Kees, Kenneth L., Ted Smith, Michael L. McCaleb, et al.. (1992). Perfluorocarbon-based antidiabetic agents. Journal of Medicinal Chemistry. 35(5). 944–953. 24 indexed citations
16.
Gilligan, Paul J., Gary A. Cain, Thomas E. Christos, et al.. (1992). Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs. Journal of Medicinal Chemistry. 35(23). 4344–4361. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026